Cyclic Vomiting Syndrome (CVS): is there a difference based on onset of symptoms - pediatric versus adult?
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Background: Cyclic Vomiting Syndrome (CVS) is a well-recognized functional gastrointestinal disorder in children but its presentation is poorly understood in adults. Genetic differences in pediatric-onset (presentation before age 18) and adult-onset CVS have been reported recently but their clinical features and possible differences in response to therapy have not been well studied. Methods: This was a retrospective review of 101 CVS patients seen at the Medical College of Wisconsin between 2006 and 2008. Rome III criteria were utilized to make the diagnosis of CVS. Results: Our study population comprised of 29(29%) pediatric-onset and 72 (71%) adult-onset CVS patients. Pediatric-onset CVS patients were more likely to be female (86% vs. 57%, p = 0.005) and had a higher prevalence of CVS plus (CVS + neurocognitive disorders) as compared to adult-onset CVS patients (14% vs. 3%, p = 0.05). There was a longer delay in diagnosis (10 ± 7 years) in the pediatric-onset group when compared to (5 ± 7 years) adult-onset CVS group (p = 0.001). Chronic opiate use was less frequent in the pediatric-onset group compared to adult-onset patients (0% vs. 23%, p = 0.004). Aside from these differences, the two groups were similar with regards to their clinical features and the time of onset of symptoms did not predict response to standard treatment. The majority of patients (86%) responded to treatment with tricyclic antidepressants, anticonvulsants (topiramate), coenzyme Q-10, and L-carnitine. Non-response to therapy was associated with coalescence of symptoms, chronic opiate use and more severe disease as characterized by longer episodes, greater number of emergency department visits in the year prior to presentation, presence of disability and non-compliance on univariate analysis. On multivariate analysis, only compliance to therapy was associated with a response. (88% vs. 38%, Odds Ratio, OR 9.6; 95% Confidence Interval [CI], 1.18-77.05). Conclusion: Despite reported genetic differences, the clinical features and response to standard therapy in pediatric- and adult-onset CVS were mostly similar. Most patients (86%) responded to therapy and compliance was the only factor associated with a response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The evidence on the use of TCAs in adults with CVS is based on open‐label and retrospective studies and two randomized controlled trials (RCTs) in children.”
From Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mean effective dose in adults is 75‐100 mg daily or 1‐1.5 mg/kg body weight.”
From Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a retrospective study of 18 adults treated with prophylactic topiramate, 72% had ≥50% reduction in frequency/severity of CVS episodes.”
From Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Across these studies, 413/600 (70%) of patients reported complete or partial improvement with a decrease in frequency, duration, or severity of CVS symptoms when treated with a TCA, most commonly amitriptyline.”
From Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Kumar et al3 in a retrospective study of 70 patients showed that the majority of patients (86%) responded to treatment with AT.”
From Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) · cites this paper as [3]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional Gastroduodenal Disorders
Tack, J., Talley, N. J., Camilleri, M., Holtmann, G., Hu, P., Malagelada, J.-R., & Stanghellini, V. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.059 · Cited by 2,418
Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse
Allen, J. H., de Moore, G. M., Heddle, R., & Twartz, J. C. (2004) · Gut · doi:10.1136/gut.2003.036350 · Cited by 529
Li, B. U., Lefevre, F., Chelimsky, G. G., Boles, R. G., Nelson, S. P., Lewis, D. W., Linder, S. L., Issenman, R. M., & Rudolph, C. D. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318173ed39 · Cited by 290 · cited 1×
“Strong maternal inheritance of multiple disease manifestations and abnormal urine organic acids has been demonstrated in children with CVS, suggesting the presence of predisposing mtDNA sequence polymorphisms [12,13].”
BackgroundCyclic Vomiting Syndrome in 41 adults: the illness, the patients, and problems of management
Fleisher, D. R., Gornowicz, B., Adams, K., Burch, R., & Feldman, E. J. (2005) · BMC Medicine · doi:10.1186/1741-7015-3-20 · Cited by 215 · cited 2×
“Several CVS patients also undergo unnecessary surgical procedures such as cholecystectomy for symptoms caused by CVS [7].”
Cyclic vomiting syndrome in adults
Abell, T. L., Adams, K. A., Boles, R. G., Bousvaros, A., Chong, S. K. F., Fleisher, D. R., Hasler, W. L., Hyman, P. E., Issenman, R. M., Li, B. U. K., et al. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01113.x · Cited by 194 · cited 6×
“Six patients met the diagnostic criteria for CVS plus whereas 10 patients met criteria for catamenial CVS (episodes triggered by menstrual periods) [1].”
BackgroundMethodInfluentialIs cyclic vomiting syndrome related to migraine?
Li, B. U. K., Murray, R. D., Heitlinger, L. A., Robbins, J. L., & Hayes, J. R. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70242-8 · Cited by 185
The Cyclic Vomiting Syndrome: A Report of 71 Cases and Literature Review
Fleisher, D. R., & Matar, M. (1993) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.1993.tb10995.x · Cited by 170
Zaki, E., Freilinger, T., Klopstock, T., Baldwin, E., Heisner, K., Adams, K., Dichgans, M., Wagler, S., & Boles, R. (2009) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01793.x · Cited by 161
Cyclic Vomiting Syndrome in Adults: Clinical Features and Response to Tricyclic Antidepressants
Prakash, C., & Clouse, R. E. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01428.x · Cited by 123
Andersen, J. M., Sugerman, K. S., Lockhart, J. R., & Weinberg, W. A. (1997) · Pediatrics · doi:10.1542/peds.100.6.977 · Cited by 122
Cited by
Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome
Venkatesan, T., Levinthal, D. J., Li, B. U. K., Tarbell, S. E., Adams, K. A., Issenman, R. M., Sarosiek, I., Jaradeh, S. S., Sharaf, R., Sultan, S., et al. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13606 · Cited by 173
Self-citationVenkatesan, T., Levinthal, D. J., Tarbell, S. E., Jaradeh, S. S., Hasler, W. L., Issenman, R. M., Adams, K. A., Sarosiek, I., Stave, C. D., Sharaf, R. N., et al. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13604 · Cited by 137
Self-citationA link between gastrointestinal disorders and migraine: Insights into the gut–brain connection
Aurora, S. K., Shrewsbury, S. B., Ray, S., Hindiyeh, N. A., & Nguyen, L. A. B. (2021) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14099 · Cited by 90
An Internet survey of marijuana and hot shower use in adults with cyclic vomiting syndrome (CVS)
Venkatesan, T., Sengupta, J., Lodhi, A., Schroeder, A., Adams, K., Hogan, W. J., Wang, Y., Andrews, C., & Storr, M. (2014) · Experimental Brain Research · doi:10.1007/s00221-014-3967-0 · Cited by 86
“Previous studies have noted that 37–38 % of patients with cVs use marijuana (choung et al. 2012; Kumar et al. 2012). these observations may be limited by significant reporting bias in a clinic setting where marijuana use is illegal in many states in the Usa, and patients may be reluctant to admit…”
Self-citationPediatric Migraine Variants: a Review of Epidemiology, Diagnosis, Treatment, and Outcome
Lagman‐Bartolome, A. M., & Lay, C. L. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0551-3 · Cited by 86
Metadata
- Authors
- Kumar, N., Bashar, Q., Reddy, N., Sengupta, J., Ananthakrishnan, A., Schroeder, A., Hogan, W. J., & Venkatesan, T.
- Affiliations
- Medical College of Wisconsin (US)
- Mayo Clinic in Florida (US)
- Wayne State University (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Venkatesan, Thangam
- Venue
- BMC Gastroenterology
- Published
- 2012-05-28
- Volume
- 12
- Issue
- 1
- Pages
- 52-52
- ISSN
- 1471-230X (ISSN-L)
- PMC
- PMC3443054
- OpenAlex
- W1997236431
- Cited by
- 96
- References
- 24
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 14 · 2023: 8 · 2022: 9 · 2021: 9 · 2020: 3 · 2019: 8 · 2018: 5 · 2017: 6 · 2016: 4 · 2015: 4 · 2014: 7 · 2013: 4
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Gastroenterology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Human Biology (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Health Sciences › Medicine › Surgery › Nausea and vomiting management
- Keywords
- cyclic vomiting syndrome, treatment response, medication adherence, tricyclic antidepressants, topiramate, coenzyme Q10, L-carnitine, opiate use, neurocognitive disorders, functional gastrointestinal disorders, Rome III criteria, delayed diagnosis, emergency department visits, disability
- MeSH terms
- Adolescent, Adult, Anticonvulsants, Antidepressive Agents, Tricyclic, Carnitine, Child, Child, Preschool, Female, Humans, Infant, Male, Patient Compliance, Retrospective Studies, Ubiquinone, Vomiting, Wisconsin, Treatment Outcome, Age of Onset, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cyclic Vomiting Syndrome (CVS): is there a difference based on onset of symptoms - pediatric versus adult? https://app.cochat.ai/papers/10.1186/1471-230x-12-52
- The paper
- Kumar, N., Bashar, Q., Reddy, N., Sengupta, J., Ananthakrishnan, A., Schroeder, A., Hogan, W. J., & Venkatesan, T. (2012). Cyclic Vomiting Syndrome (CVS): is there a difference based on onset of symptoms - pediatric versus adult? BMC Gastroenterology. https://doi.org/10.1186/1471-230x-12-52
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

